FDA Approves Left Ventricular Assist System for Severe Heart Failure
FDA Approves Left Ventricular Assist System for Severe Heart Failure Patients
The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation.